IMMUMEDIC · European information platform for dendritic cell therapy · No promise of cure
Metastases

Metastases detected – which treatment options are available?

When metastases are found, treatment planning often changes. There is no single “metastasis treatment”: the primary tumour, location, number and dynamics of metastases, tumour biology and previous treatment are decisive.

Medically and editorially updated: 1 September 2026 · General information, not an individual treatment decision.

What are metastases?

Metastases develop when tumour cells detach from the primary tumour and form new tumour sites in other tissues or organs. They are generally named after the original cancer – for example, liver metastases from colorectal cancer remain biologically colorectal cancer cells.

Which information matters now

Current imaging, histology, extent of disease, symptoms, organ function, previous treatment and – depending on the tumour – molecular markers are considered together for treatment planning.

Which treatments may be possible

Depending on the situation, systemic treatments such as chemotherapy, hormone therapy, targeted medicines or approved immunotherapy, as well as local procedures such as surgery or radiotherapy, may be considered. Clinical trials may also be relevant.

Immunotherapy for metastatic cancer

Metastatic disease alone does not determine whether immunotherapy is suitable. Tumour type, biomarkers, previous treatment and individual risks are crucial.

Immunotherapy and metastases →

Metastases by organ

Separate overviews are available for common locations: liver metastases, lung metastases, bone metastases and brain metastases.

Important: This information does not replace medical diagnosis or treatment decisions. If symptoms are new, worsening or acute, or your condition deteriorates rapidly, contact your treating medical team immediately.

Have your individual medical records reviewed

Existing reports, histology, current imaging, previous treatments and – where available – molecular findings can be reviewed together for structured orientation.

Request a free individual therapy review

Editorial responsibility: IMMUMEDIC Limited · Portal editor Andreas Rach. Updated: 1 September 2026. No promise of cure; no recommendation to stop or delay guideline-based treatment.
ORIENTATION

Patient or medical professional?

These two pathways are intentionally separated so that enquiries can be directed appropriately.

Call Rita+49 30 439 792 5331